Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Molecular & Cellular Proteomics : MCP|April 23, 2008
Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypesAnthony Gonçalves, Emmanuelle Charafe-Jauffret, François Bertucci, et al.
Journal of Hepatology|November 16, 2020
ADAMTSL5 is an epigenetically activated gene underlying tumorigenesis and drug resistance in hepatocellular carcinomaMaria Arechederra, Sehrish K Bazai, Ahmed Abdouni, et al.
ACS Infectious Diseases|July 13, 2019
Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of <i>Mycobacterium abscessus</i>Abdeldjalil Madani, Jeremy N Ridenour, Benjamin P Martin, et al.
ACS Infectious Diseases|May 29, 2025
Mapping of Mycobacterial Enzymes Involved in Triacylglycerol Accumulation as Intrabacterial Lipid Inclusions Using Activity-Based Multitarget Inhibitor ProbesRomain Avellan, Jordan Lehoux, Thomas Francis, et al.
The Journal of Experimental Medicine|September 21, 2016
The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cellsRomain Roncagalli, Margot Cucchetti, Nicolas Jarmuzynski, et al.
Clinical Epigenetics|October 14, 2019
Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutationSylvain Garciaz, Lia N'guyen Dasi, Pascal Finetti, et al.
BMC Biology|July 31, 2023
Population transcriptogenomics highlights impaired metabolism and small population sizes in tree frogs living in the Chernobyl Exclusion ZoneClément Car, André Gilles, Elen Goujon, et al.
EMBO Molecular Medicine|December 27, 2021
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanomaIlona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, et al.
EMBO Reports|March 15, 2021
ARHGAP45 controls naïve T- and B-cell entry into lymph nodes and T-cell progenitor thymus seedingLe He, Marie-Pierre Valignat, Lichen Zhang, et al.
Blood|June 19, 2010
The cell polarity PTK7 receptor acts as a modulator of the chemotherapeutic response in acute myeloid leukemia and impairs clinical outcomeThomas Prebet, Anne-Catherine Lhoumeau, Christine Arnoulet, et al.
Pageof 10